Early change in faecal calprotectin during anti-TNFα initiation is strongly predictive of outcome in Crohn's disease

被引：0
|
作者：
Pavlidis, P. [1 ]
Chung-Faye, G. [1 ]
Dubois, P. [1 ]
Bjarnason, I. [1 ]
Hayee, B. H. [1 ]
机构：
[1] Kings Coll Hosp London, Dept Gastroenterol, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P470
引用
收藏
页码：S338 / S338
页数：1
相关论文
共 50 条
  • [1] Early change in faecal calprotectin predicts primary non-response to anti-TNF therapy in Crohn's disease
    Pavlidis, Polychronis
    Gulati, Shraddha
    Dubois, Patrick
    Chung-Faye, Guy
    Sherwood, Roy
    Bjarnason, Ingvar
    Hayee, Bu'Hussain
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (12) : 1447 - 1452
  • [2] Faecal calprotectin can be used to monitor response to therapy in anti-TNF treated patients with Crohn's disease
    Saleem, R.
    Dubois, P.
    Chung-Faye, G.
    Bjarnason, I.
    Hayee, B.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S268 - S268
  • [3] Faecal calprotectin as therapeutic target in patients with Crohn's disease treated with anti-TNF: a meta-analysis of individual data
    Mami, A.
    Nancey, S.
    Pugliese, D.
    Molander, P.
    Boschetti, G.
    Nogueira, I.
    Pereira, B.
    Buisson, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S205 - S206
  • [4] FAECAL CALPROTECTIN AS THERAPEUTIC TARGET IN PATIENTS WITH CROHN'S DISEASE TREATED WITH ANTI-TNF: A META-ANALYSIS OF INDIVIDUAL DATA
    Mami, Alia
    Nancey, Stephane
    Pugliese, Daniela
    Molander, Pauliina
    Boschetti, Gilles
    Nogueira, Islaine
    Pereira, Bruno
    Buisson, Anthony
    GASTROENTEROLOGY, 2020, 158 (06) : S708 - S708
  • [5] FAECAL CALPROTECTIN IDENTIFIES NON RESPONDERS TO ANTI-TNF THERAPY WHEN MEASURED AFTER INDUCTION IN INFLAMMATORY CROHN'S DISEASE
    Pavlidis, P.
    Cavazza, A.
    Siddique, N.
    Stamoulos, P.
    Tumova, J.
    Medcalf, L.
    Chung-Faye, G.
    Dubois, P.
    Bjarnason, I.
    Hayee, B.
    GUT, 2015, 64 : A431 - A432
  • [6] PREDICTIVE FACTORS FOR LOSS OF RESPONSE TO ANTI-TNF IN CROHN'S DISEASE
    Moreira dos Santos, Byanca Rossetti
    Marques dos Santos, Carlos Henrique
    Moreira dos Santos, Vitoria Rossetti
    Garcia Torrez, Claudia Yanina
    Palomares-Junior, Daniel
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2020, 33 (02):
  • [7] The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease
    Sollelis, E.
    Quinard, R. Minet
    Bouguen, G.
    Goutte, M.
    Goutorbe, F.
    Bouvier, D.
    Pereira, B.
    Bommelaer, G.
    Buisson, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S360 - S360
  • [8] EARLY INITIATION OF ANTI-TNF THERAPY IS COST-SAVING COMPARED TO LATE INITIATION FOR PATIENTS WITH CROHN'S DISEASE
    Beilman, Candace L.
    Kirwin, Erin
    Ma, Christopher
    McCabe, Christopher
    Fedorak, Richard N.
    Halloran, Brendan P.
    GASTROENTEROLOGY, 2017, 152 (05) : S137 - S137
  • [9] Anti-TNF therapy and Crohn's disease
    Peyrin-Biroulet, L.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 478 - 481
  • [10] Anti-TNF Therapy in Crohn's Disease
    Adegbola, Samuel O.
    Sahnan, Kapil
    Warusavitarne, Janindra
    Hart, Ailsa
    Tozer, Philip
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
12345